Mosaburo Kainuma

1.1k citations
74 papers · 733 indexed · h-index 16
Topics
Hepatitis C virus research (21 papers)Hepatitis B Virus Studies (13 papers)Pharmacological Effects of Natural Compounds (12 papers)

In The Last Decade

Mosaburo Kainuma

65 papers receiving 714 citations

Peers

Mosaburo Kainuma
Comparison fields: 5 of 97
  • Epidemiology 339
  • Hepatology 271
  • Molecular Biology 84
  • Endocrinology, Diabetes and Metabolism 83
  • Infectious Diseases 80
Replace Marcel Sorribas with:
Marcel Sorribas Switzerland
Yasuhiro Nishizaki Japan
Yoshitaka Fukuzawa Japan
Beom Jae Lee South Korea
Jaya Benjamin India
Zhanguo Liu China
Gülşen Özbay Türkiye
Oriol Juanola Spain
Mehmet Koruk Türkiye
Mosaburo Kainuma relative to Marcel Sorribas Switzerland Marcel Sorribas's profile →
Citations per field
00.5×10×20×34×
Marcel Sorribas · 1×
Citations per year

Countries citing papers authored by Mosaburo Kainuma

Since Specialization
Citations

This map shows the geographic impact of Mosaburo Kainuma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mosaburo Kainuma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mosaburo Kainuma more than expected).

Fields of papers citing papers by Mosaburo Kainuma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mosaburo Kainuma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mosaburo Kainuma. The network helps show where Mosaburo Kainuma may publish in the future.

Co-authorship network of co-authors of Mosaburo Kainuma

This figure shows the co-authorship network connecting the top 25 collaborators of Mosaburo Kainuma. A scholar is included among the top collaborators of Mosaburo Kainuma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mosaburo Kainuma. Mosaburo Kainuma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 0
4 4
5 0
6 4
7 15
8 3
9 2
10 11
11 3
12 33
13 3
14 11
15 36
16 0
17 4
18 1
19 4
20 4

About Mosaburo Kainuma

Mosaburo Kainuma is a scholar working on Hepatology, Pharmacology and Complementary and alternative medicine, having authored 74 papers that have together received 733 indexed citations. Recurring topics across this work include Hepatitis C virus research (21 papers), Hepatitis B Virus Studies (13 papers) and Pharmacological Effects of Natural Compounds (12 papers). The work is most often cited by research in Hepatology (271 citations), Epidemiology (339 citations) and Complementary and alternative medicine (73 citations). Mosaburo Kainuma has collaborated with scholars based in Japan, United States and Vietnam. Frequent co-authors include Norihiro Furusyo, Masayuki Murata, Eiichi Ogawa, Jun Hayashi, Kazuhiro Toyoda, Katsutoshi TERASAWA, Yutaka Shimada, Hiroaki Ikezaki, Takeshi Ihara and Nobuyasu SEKIYA. Their work appears in journals such as Gastroenterology, PLoS ONE and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026